Suchergebnisse - "Bücklein, Veit"

PubPharm (85)

1

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

2

Friday Leukemia-a Structural Phenomenon

enthalten in: Deutsches Arzteblatt international | 2024

von Rausch, C. | Arnreich, C. | Rothenberg-Thurley, M. | +16

3

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia : a preclinical assessment

enthalten in: Leukemia | 2024

von Hänel, G. | Schönle, A. | Neumann, A. | +15

4

Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy

enthalten in: Annals of hematology | 2024

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

5

Novel immunotherapies in the treatment of AML : is there hope?

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Subklewe, M. | Bücklein, V. | Sallman, D. | +1

6

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American journal of hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

7

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

enthalten in: Blood advances | 2023

von Blumenberg, V. | Busch, G. | Baumann, S. | +24

8

Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy

enthalten in: Journal for immunotherapy of cancer | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

9

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

enthalten in: Science advances | 2023

von Rejeski, K. | Perez, A. | Iacoboni, G. | +23

10

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

enthalten in: Cytotherapy | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

1
2
3
4
5
6
7
8
9
Nächster »
[9]